CYP2E1 (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "CYP2E1" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

13nih.gov

4^th place

8^th place

12doi.org

2^nd place

4^th place

1bioline.org.br

low place

1harvard.edu

18^th place

51^st place

1fass.se

low place

1iupui.edu

9,528^th place

low place

bioline.org.br

Glew, Robert H. «You Can Get There From Here: Acetone, Anionic Ketones and Even-Carbon Fatty Acids can Provide Substrates for Gluconeogenesis». Consultado em 5 de março de 2017

doi.org

dx.doi.org

Lewis DF, Lake BG, Bird MG, Loizou GD, Dickins M, Goldfarb PS (Fevereiro de 2003). «Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme-substrate and enzyme-inhibitor interactions». Toxicology in Vitro. 17 (1): 93–105. PMID 12537967. doi:10.1016/s0887-2333(02)00098-x
Rendic S, Di Carlo FJ (1997). «Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors». Drug Metabolism Reviews. 29 (1-2): 413–580. PMID 9187528. doi:10.3109/03602539709037591
Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I (Setembro de 2007). «Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues». Pharmacogenetics and Genomics. 17 (9): 731–42. PMID 17700362. doi:10.1097/FPC.0b013e32810f2e58
Miller ON, Bazzano G (Julho de 1965). «Propanediol metabolism and its relation to lactic acid metabolism». Annals of the New York Academy of Sciences. 119 (3): 957–73. Bibcode:1965NYASA.119..957M. PMID 4285478. doi:10.1111/j.1749-6632.1965.tb47455.x
Ruddick JA (1972). «Toxicology, metabolism, and biochemistry of 1,2-propanediol». Toxicol App Pharmacol. 21: 102–111. doi:10.1016/0041-008X(72)90032-4
Porubsky PR, Meneely KM, Scott EE (Novembro de 2008). «Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates». The Journal of Biological Chemistry. 283 (48): 33698–707. PMC 2586265. PMID 18818195. doi:10.1074/jbc.M805999200
Westphal C, Konkel A, Schunck WH (Novembro de 2011). «CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?». Prostaglandins & Other Lipid Mediators. 96 (1–4): 99–108. PMID 21945326. doi:10.1016/j.prostaglandins.2011.09.001
Fleming I (Outubro de 2014). «The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease». Pharmacological Reviews. 66 (4): 1106–40. PMID 25244930. doi:10.1124/pr.113.007781
Zhang G, Kodani S, Hammock BD (Janeiro de 2014). «Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer». Progress in Lipid Research. 53: 108–23. PMC 3914417. PMID 24345640. doi:10.1016/j.plipres.2013.11.003
He J, Wang C, Zhu Y, Ai D (Dezembro de 2015). «Soluble epoxide hydrolase: A potential target for metabolic diseases». Journal of Diabetes. 8 (3): 305–13. PMID 26621325. doi:10.1111/1753-0407.12358
Wagner K, Vito S, Inceoglu B, Hammock BD (Outubro de 2014). «The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling». Prostaglandins & Other Lipid Mediators. 113-115: 2–12. PMC 4254344. PMID 25240260. doi:10.1016/j.prostaglandins.2014.09.001
Fischer R, Konkel A, Mehling H, Blossey K, Gapelyuk A, Wessel N, von Schacky C, Dechend R, Muller DN, Rothe M, Luft FC, Weylandt K, Schunck WH (Março de 2014). «Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway». Journal of Lipid Research. 55 (6): 1150–1164. PMC 4031946. PMID 24634501. doi:10.1194/jlr.M047357

fass.se

Swedish environmental classification of pharmaceuticals Facts for prescribers (Fakta för förskrivare)

harvard.edu

ui.adsabs.harvard.edu

Miller ON, Bazzano G (Julho de 1965). «Propanediol metabolism and its relation to lactic acid metabolism». Annals of the New York Academy of Sciences. 119 (3): 957–73. Bibcode:1965NYASA.119..957M. PMID 4285478. doi:10.1111/j.1749-6632.1965.tb47455.x

iupui.edu

medicine.iupui.edu

Flockhart DA (2007). «Drug Interactions: Cytochrome P₄₅₀ Drug Interaction Table». Indiana University School of Medicine Recuperado em julho 2011

nih.gov

ncbi.nlm.nih.gov

Lewis DF, Lake BG, Bird MG, Loizou GD, Dickins M, Goldfarb PS (Fevereiro de 2003). «Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme-substrate and enzyme-inhibitor interactions». Toxicology in Vitro. 17 (1): 93–105. PMID 12537967. doi:10.1016/s0887-2333(02)00098-x
Rendic S, Di Carlo FJ (1997). «Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors». Drug Metabolism Reviews. 29 (1-2): 413–580. PMID 9187528. doi:10.3109/03602539709037591
Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I (Setembro de 2007). «Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues». Pharmacogenetics and Genomics. 17 (9): 731–42. PMID 17700362. doi:10.1097/FPC.0b013e32810f2e58
Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (Julho de 1994). «Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians». The Journal of Pharmacology and Experimental Therapeutics. 270 (1): 414–23. PMID 8035341
Hayashi S, Watanabe J, Kawajiri K (Outubro de 1991). «Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene». Journal of Biochemistry. 110 (4): 559–65. PMID 1778977
Miller ON, Bazzano G (Julho de 1965). «Propanediol metabolism and its relation to lactic acid metabolism». Annals of the New York Academy of Sciences. 119 (3): 957–73. Bibcode:1965NYASA.119..957M. PMID 4285478. doi:10.1111/j.1749-6632.1965.tb47455.x
Porubsky PR, Meneely KM, Scott EE (Novembro de 2008). «Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates». The Journal of Biological Chemistry. 283 (48): 33698–707. PMC 2586265. PMID 18818195. doi:10.1074/jbc.M805999200
Westphal C, Konkel A, Schunck WH (Novembro de 2011). «CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?». Prostaglandins & Other Lipid Mediators. 96 (1–4): 99–108. PMID 21945326. doi:10.1016/j.prostaglandins.2011.09.001
Fleming I (Outubro de 2014). «The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease». Pharmacological Reviews. 66 (4): 1106–40. PMID 25244930. doi:10.1124/pr.113.007781
Zhang G, Kodani S, Hammock BD (Janeiro de 2014). «Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer». Progress in Lipid Research. 53: 108–23. PMC 3914417. PMID 24345640. doi:10.1016/j.plipres.2013.11.003
He J, Wang C, Zhu Y, Ai D (Dezembro de 2015). «Soluble epoxide hydrolase: A potential target for metabolic diseases». Journal of Diabetes. 8 (3): 305–13. PMID 26621325. doi:10.1111/1753-0407.12358
Wagner K, Vito S, Inceoglu B, Hammock BD (Outubro de 2014). «The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling». Prostaglandins & Other Lipid Mediators. 113-115: 2–12. PMC 4254344. PMID 25240260. doi:10.1016/j.prostaglandins.2014.09.001
Fischer R, Konkel A, Mehling H, Blossey K, Gapelyuk A, Wessel N, von Schacky C, Dechend R, Muller DN, Rothe M, Luft FC, Weylandt K, Schunck WH (Março de 2014). «Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway». Journal of Lipid Research. 55 (6): 1150–1164. PMC 4031946. PMID 24634501. doi:10.1194/jlr.M047357